Therapeutic continuity in Alzheimer's disease

switching patients to galantamine. Panel discussion: recommendations for prescribers.

J. C. Morris, Martin Farlow, S. H. Ferris, A. F. Kurz, A. Maelicke, L. Rasmusen, D. Wilkinson, B. Yan

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
JournalClinical Therapeutics
Volume23 Suppl A
StatePublished - 2001

Fingerprint

Galantamine
Cholinesterase Inhibitors
Alzheimer Disease
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Therapeutic continuity in Alzheimer's disease : switching patients to galantamine. Panel discussion: recommendations for prescribers. / Morris, J. C.; Farlow, Martin; Ferris, S. H.; Kurz, A. F.; Maelicke, A.; Rasmusen, L.; Wilkinson, D.; Yan, B.

In: Clinical Therapeutics, Vol. 23 Suppl A, 2001.

Research output: Contribution to journalArticle

Morris, JC, Farlow, M, Ferris, SH, Kurz, AF, Maelicke, A, Rasmusen, L, Wilkinson, D & Yan, B 2001, 'Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.', Clinical Therapeutics, vol. 23 Suppl A.
Morris, J. C. ; Farlow, Martin ; Ferris, S. H. ; Kurz, A. F. ; Maelicke, A. ; Rasmusen, L. ; Wilkinson, D. ; Yan, B. / Therapeutic continuity in Alzheimer's disease : switching patients to galantamine. Panel discussion: recommendations for prescribers. In: Clinical Therapeutics. 2001 ; Vol. 23 Suppl A.
@article{1d208b65e605496e82727308ff4ee885,
title = "Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.",
author = "Morris, {J. C.} and Martin Farlow and Ferris, {S. H.} and Kurz, {A. F.} and A. Maelicke and L. Rasmusen and D. Wilkinson and B. Yan",
year = "2001",
language = "English (US)",
volume = "23 Suppl A",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",

}

TY - JOUR

T1 - Therapeutic continuity in Alzheimer's disease

T2 - switching patients to galantamine. Panel discussion: recommendations for prescribers.

AU - Morris, J. C.

AU - Farlow, Martin

AU - Ferris, S. H.

AU - Kurz, A. F.

AU - Maelicke, A.

AU - Rasmusen, L.

AU - Wilkinson, D.

AU - Yan, B.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=18044401800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044401800&partnerID=8YFLogxK

M3 - Article

VL - 23 Suppl A

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

ER -